oxycodone has been researched along with Musculoskeletal Pain in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 4 (30.77) | 2.80 |
| Authors | Studies |
|---|---|
| Caravaggio, S; Coluzzi, F; Rosiello, F; Ruggeri, M; Santori, C; Signorini, A | 1 |
| Marwaha, S | 1 |
| Adewunmi, V; Friedman, BW; Gupta, C; Sapkota, A; Takematsu, M; Williams, AR | 1 |
| Bijur, PE; Borrayes, L; Costa, V; Feliciano, C; Friedman, BW; Irizarry, E; Izzo, AJ; Restivo, A | 1 |
| Steurer, J | 1 |
| Caspi, S; Khoury, M; Peless, E; Raiizman, E; Salameh, S; Stalnikowics, R | 1 |
| Hayashi, Y; Inoue, K; Kubo, K; Kurozumi, K; Matsumoto, H; Nagai, S; Ohkubo, F; Takei, H; Tsuboi, M | 1 |
| Coluzzi, F; Ruggeri, M | 2 |
| Gatta, L; Scarpignato, C | 1 |
| Alarcão, J; Costa, J; Fareleira, F; Santos, J; Vaz-Carneiro, A | 1 |
| Bijur, PE; Chang, AK; Gallagher, EJ; Holden, L | 1 |
| Boisvert, L; Copeland, J; Osmun, WE; Parr, J | 1 |
2 review(s) available for oxycodone and Musculoskeletal Pain
| Article | Year |
|---|---|
Clinical and economic evaluation of tapentadol extended release and oxycodone/naloxone extended release in comparison with controlled release oxycodone in musculoskeletal pain.
Topics: Chronic Pain; Cost-Benefit Analysis; Delayed-Action Preparations; Humans; Italy; Musculoskeletal Pain; Naloxone; Oxycodone; Phenols; Tapentadol; Treatment Outcome | 2014 |
Tapentadol for chronic musculoskeletal pain in adults.
Topics: Adult; Analgesics, Opioid; Chronic Pain; Clinical Trials, Phase III as Topic; Humans; Low Back Pain; Musculoskeletal Pain; Osteoarthritis, Knee; Oxycodone; Phenols; Randomized Controlled Trials as Topic; Tapentadol | 2015 |
4 trial(s) available for oxycodone and Musculoskeletal Pain
| Article | Year |
|---|---|
Oxycodone induced euphoria in ED patients with acute musculoskeletal pain. A secondary analysis of data from a randomized trial.
Topics: Acetaminophen; Acute Pain; Analgesics, Opioid; Double-Blind Method; Drug Combinations; Euphoria; Humans; Musculoskeletal Pain; Oxycodone | 2022 |
A randomized controlled trial of oxycodone/acetaminophen versus acetaminophen alone for emergency department patients with musculoskeletal pain refractory to ibuprofen.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Analgesics, Opioid; Double-Blind Method; Emergency Service, Hospital; Humans; Ibuprofen; Musculoskeletal Pain; Oxycodone | 2021 |
Topics: Acetaminophen; Adult; Codeine; Double-Blind Method; Drug Combinations; Emergency Service, Hospital; Extremities; Female; Humans; Hydrocodone; Male; Middle Aged; Musculoskeletal Pain; New York; Oxycodone; Pain Measurement; Young Adult | 2018 |
Comparative Analgesic Efficacy of Oxycodone/Acetaminophen Versus Hydrocodone/Acetaminophen for Short-term Pain Management in Adults Following ED Discharge.
Topics: Acetaminophen; Acute Pain; Adult; Analgesics; Double-Blind Method; Drug Combinations; Emergency Service, Hospital; Extremities; Female; Humans; Hydrocodone; Male; Middle Aged; Musculoskeletal Pain; Oxycodone; Pain Management; Pain Measurement; Patient Discharge; Patient Satisfaction; Prospective Studies | 2015 |
7 other study(ies) available for oxycodone and Musculoskeletal Pain
| Article | Year |
|---|---|
Cost-Effectiveness Analysis of Tapentadol Versus Oxycodone/Naloxone in both Branded and Generic Formulations in Patients with Musculoskeletal Pain.
Topics: Analgesics, Opioid; Cost-Benefit Analysis; Delayed-Action Preparations; Humans; Musculoskeletal Pain; Naloxone; Oxycodone; Phenols; State Medicine; Tapentadol | 2021 |
JK.
Topics: Accidents, Traffic; Acetaminophen; Analgesics, Opioid; Anxiety; Drug Combinations; Family Relations; Female; Humans; Musculoskeletal Pain; Opioid-Related Disorders; Oxycodone; Professional-Patient Relations; Self Concept | 2021 |
Emergency Department Administration of Oxycodone by Nurses Treating Musculoskeletal Pain: An Observational Prospective.
Topics: Adult; Analgesics, Opioid; Emergency Nursing; Emergency Service, Hospital; Female; Humans; Male; Musculoskeletal Pain; Oxycodone; Prospective Studies; Treatment Outcome | 2018 |
[Efficacy and tolerability of controlled-release oxycodone against nab-paclitaxel-induced musculoskeletal pain in breast cancer patients].
Topics: Adult; Aged; Albumins; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Humans; Middle Aged; Musculoskeletal Pain; Oxycodone; Paclitaxel | 2013 |
Comparing tapentadol to oxycodone/naloxone combination: building castles in the air.
Topics: Chronic Pain; Humans; Musculoskeletal Pain; Naloxone; Oxycodone; Phenols | 2015 |
Comparing tapentadol to oxycodone/naloxone combination: imagining castles in the air … while building sandcastles! Re: Coluzzi F, Ruggeri M. Clinical and economic evaluation of tapentadol extended release and oxycodone/naloxone extended release in compari
Topics: Chronic Pain; Humans; Musculoskeletal Pain; Naloxone; Oxycodone; Phenols | 2015 |
Characteristics of chronic pain patients in a rural teaching practice.
Topics: Adult; Aged; Alcohol-Related Disorders; Analgesics, Opioid; Back Pain; Chronic Pain; Female; Health Status; Humans; Male; Middle Aged; Musculoskeletal Pain; Office Visits; Ontario; Opioid-Related Disorders; Oxycodone; Primary Health Care; Retrospective Studies; Rural Health Services; Tobacco Use Disorder | 2011 |